Monday, 6 July 2020

WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19

WHO accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue the trial’s hydroxychloroquine and lopinavir/ritonavir arms. The Solidarity Trial was established by WHO to find an effective COVID-19 treatment for hospitalized patients.



source https://www.pharmatutor.org/pharma-news/2020/who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Pharmaceutical jobs for MPharm / MSc / BPharm or BSc - DPharm or PharmD and PhD

  Openings for Pharmacists under the National Health Mission Degree or Diploma in Pharmacy (50%) & Registration in CG Pharmacy Registrat...